News
ICEBERG study demonstrates improved outcomes of nasal spray for TRD
Janssen’s ICEBERG study has demonstrated that esketamine nasal spray (NS) has shown improved outcomes in an indirect treatment comparison with other real-world treatments for treatment-resistant depression (TRD).